scispace - formally typeset
A

Alfred Pühler

Researcher at Bielefeld University

Publications -  662
Citations -  49153

Alfred Pühler is an academic researcher from Bielefeld University. The author has contributed to research in topics: Gene & Plasmid. The author has an hindex of 102, co-authored 658 publications receiving 45871 citations. Previous affiliations of Alfred Pühler include Facultad de Ciencias Exactas y Naturales & National University of La Plata.

Papers
More filters
Journal ArticleDOI

A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in Gram negative bacteria

TL;DR: In this paper, a new vector strategy for the insertion of foreign genes into the genomes of gram negative bacteria not closely related to Escherichia coli was developed, which can utilize any gram negative bacterium as a recipient for conjugative DNA transfer.
Journal ArticleDOI

Small mobilizable multi-purpose cloning vectors derived from the Escherichia coli plasmids pK18 and pK19: selection of defined deletions in the chromosome of Corynebacterium glutamicum

TL;DR: Small mobilizable vectors based on the Escherichia coli plasmids pK18 and pK19 can be transferred by RP4-mediated conjugation into a wide range of Gram- and Gram+ bacteria, and should facilitate gene disruption and allelic exchange by homologous recombination.
Journal ArticleDOI

The composite genome of the legume symbiont Sinorhizobium meliloti.

TL;DR: The annotated DNA sequence of the α-proteobacteriumSinorhizobium meliloti, the symbiont of alfalfa, is presented, indicating that all three elements contribute, in varying degrees, to symbiosis and reveals how this genome may have emerged during evolution.
Journal ArticleDOI

Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment.

Jonas Schulte-Schrepping, +137 more
- 17 Sep 2020 - 
TL;DR: This study provides detailed insights into the systemic immune response to SARS-CoV-2 infection and it reveals profound alterations in the myeloid cell compartment associated with severe COVID-19.